neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline

Rare Disease

MONDO:0030028

Also known as:

CONATOCneurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline

Genes

Clinical Trials

–

Newborn Screening

–

Patient Groups

–

Patient-Friendly Information

Comprehensive, easy-to-understand information about this condition

How we create this content →

Report Generation Failed

We couldn't automatically generate the report. This may be due to temporary service issues.

Companies Active in neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline

0 approved

Organizations with approved therapies for this disease

No approved therapies yet

Research is ongoing — 3 companies have orphan drug designations for this disease

Calliditas Therapeutics AB

Other

Designated

Genetix Biotherapeutics Inc.

Other

Designated

NX Development Corp.

Other

Designated

View all companies active in neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline

Need this data in your product?

Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.

Explore API Start Free

← Back to All Diseases